Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Establishment of General Tissue Response Classification System After Chemotherapy According to Gastric Cancer Patients With Neoadjuvant Chemotherapy

NCT03791268 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT03791268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03791268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Establishment of General Tissue Response Classification System After Chemotherapy According to Gastric Cancer Patients With Neoadjuvant Chemotherapy
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
December 31, 2020
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach adenocarcinoma